Clinical Trial: Exosomal membrane proteins combined with plasma proteomics to explore early diagnostic predictive markers for chronic critical illness in children with sepsis (China)

Posted On: 2026-08-24

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exosomal membrane proteins combined with plasma proteomics to explore early diagnostic predictive markers for chronic critical illness in children with sepsis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130571

Registration Time: 2026/08/21

Type: Observational study

Primary Sponsor: Children's Hospital of Chongqing Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=291181

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Exosomal membrane proteins combined with plasma proteomics to explore early diagnostic predictive markers for chronic critical illness in children with sepsis (China)